Six-Month Outcome Scores Predicts Short-Term Outcomes After Hip Arthroscopy.


Journal

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
ISSN: 1526-3231
Titre abrégé: Arthroscopy
Pays: United States
ID NLM: 8506498

Informations de publication

Date de publication:
10 2021
Historique:
received: 02 08 2020
revised: 16 03 2021
accepted: 17 03 2021
pubmed: 4 4 2021
medline: 26 10 2021
entrez: 3 4 2021
Statut: ppublish

Résumé

To determine whether early patient-reported outcome improvements in the 6 months after surgery are predictive of achieving a patient acceptable symptomatic state (PASS) at 2 years. A prospectively collected database was retrospectively reviewed. Inclusion criteria included patients ≥18 years of age, Tönnis grade 0 or 1 changes, radiographic imaging consistent with femoroacetabular impingement or labral pathology, a primary diagnosis of symptomatic femoroacetabular impingement for which they underwent primary hip arthroscopy, and baseline, 6-month, and 2-year modified Harris Hip Score (mHHS) scores. Revision cases were excluded. Receiver operating characteristic curve analysis was conducted to determine whether 6-month change in mHHS was a predictor for achieving PASS at 2 years. There were 173 patients (mean age: 39.8, 61.8% female) included within the study. Patients who do not achieve the minimal clinically important difference (MCID), defined as a change of 8 points in mHHS, by 6 months (n = 21) tended to have significantly lower mHHS scores at 1 year and 2 years compared with those who did (n = 152). Only 52% of patients who did not achieve MCID by 6 months achieved MCID by 2 years (vs 98% for those that did) and only 24% achieved PASS by 2 years (vs 88% that did). Using the MCID as a cutoff for improvement in mHHS at 6 months results in a 96% sensitivity but 47% specificity for predicting PASS achievement at 2 years. Using 24 points of improvement in mHHS as a cutoff at 6 months improves sensitivity and specificity to 81% and 80%, respectively. Early improvement in mHHS scores is associated with 2-year outcomes. Patients who do not achieve MCID within 6 months of surgery have a high rate of not achieving PASS at 2 years. IV, case series study.

Identifiants

pubmed: 33812033
pii: S0749-8063(21)00285-1
doi: 10.1016/j.arthro.2021.03.046
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3081-3087

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Auteurs

Charles C Lin (CC)

NYU Langone Orthopedic Hospital, New York, York, U.S.A.. Electronic address: charles.lin@nyulangone.org.

Christopher A Colasanti (CA)

NYU Langone Orthopedic Hospital, New York, York, U.S.A.

David A Bloom (DA)

NYU Langone Orthopedic Hospital, New York, York, U.S.A.

Thomas Youm (T)

NYU Langone Orthopedic Hospital, New York, York, U.S.A.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH